Data suggests that dramatic weight loss, including via GLP-1 drugs, could save Americans big bucks in healthcare spending.
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
If you’ve spent any time on TikTok, you know how quickly health trends can take off—and the 90-30-50 diet plan is the latest ...
If you’ve thought about losing weight lately, you’re not alone. And you’re far from the first guy to look up the best weight ...
Weight loss in your 30s (and beyond!) is totally possible, and the experts here have sound advice to help kickstart your ...
However, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, warned that weight loss jabs “are not a ...
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from ...
Postpartum weight loss can feel impossible at times, especially if the weight isn’t coming off as quickly as you expected.
"Platforms often promote misinformation or oversimplified solutions," one expert told Newsweek about the findings.
Those treated with tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist, lost on ...
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical ...